Prevention of atherothrombotic conditions at:
– Patients with myocardial infarct (of few days to 35 days), ischemic insult (from 7 days to 6 months), or existing peripheral arterial disease;
– Patients with non-ST segment elevation (unstable angina or non-Q myocardial infarct) in combination with acetylsalicylic acid;
– Conditions after a stent procedure.
